Chemoinformaics analysis of Adenostemmoic acid C
| Molecular Weight | 368.47 | nRot | 2 |
| Heavy Atom Molecular Weight | 336.214 | nRig | 20 |
| Exact Molecular Weight | 368.22 | nRing | 4 |
| Solubility: LogS | -2.901 | nHRing | 0 |
| Solubility: LogP | 1.202 | No. of Aliphatic Rings | 4 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 59.5494 |
| nHD | 5 | BPOL | 32.9706 |
| QED | 0.499 |
| Synth | 6.031 |
| Natural Product Likeliness | 3.078 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.214 |
| Pgp-sub | 0.685 |
| HIA | 0.459 |
| CACO-2 | -5.538 |
| MDCK | 0.0000751 |
| BBB | 0.441 |
| PPB | 0.410285 |
| VDSS | 0.338 |
| FU | 0.384166 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.555 |
| CYP2c19-inh | 0.003 |
| CYP2c19-sub | 0.272 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.056 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.109 |
| CYP3a4-inh | 0.114 |
| CYP3a4-sub | 0.04 |
| CL | 1.803 |
| T12 | 0.612 |
| hERG | 0.059 |
| Ames | 0.023 |
| ROA | 0.837 |
| SkinSen | 0.842 |
| Carcinogencity | 0.716 |
| EI | 0.216 |
| Respiratory | 0.976 |
| NR-Aromatase | 0.244 |
| Antiviral | Yes |
| Prediction | 0.595009 |